APT Medical Inc. (SHA:688617)

Market Cap	29.62B -29.6%
Revenue (ttm)	2.72B +25.2%
Net Income	866.92M +21.1%
EPS	6.13 +21.0%
Shares Out	140.64M
PE Ratio	34.36
Forward PE	27.07
Dividend	1.00 (0.46%)
Ex-Dividend Date	May 14, 2026

Volume	1,211,146
Open	219.00
Previous Close	218.75
Day's Range	209.12 - 219.00
52-Week Range	209.48 - 337.20
Beta	-0.35
Analysts	Strong Buy
Price Target	335.39 (+59.26%)
Earnings Date	Aug 21, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addit...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,118
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.